A new analysis points out the value of hepatitis C research. The researchers note that in the United States, chronic hepatitis C is the leading cause of death from liver disease and the top reason for liver transplants. Raymond T. Chung, associate professor of medicine at Massachusetts General Hospital, is a coauthor of the piece.
